Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5723240 | 0.83 | MAPT (0.52) | FFAR4KDM4EKMT2ANPC1RAB9A | |
| SCHEMBL6031384 | 0.79 | FFAR4 (0.51) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL7360407 | 0.78 | FFAR4 (0.46) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL5722811 | 0.78 | KDM4E (0.54) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL8068920 | 0.76 | FFAR4 (0.43) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL183890 | 0.74 | FFAR4 (0.44) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL3452752 | 0.74 | FFAR4 (0.46) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL7360394 | 0.70 | FFAR4 (0.46) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL8940054 | 0.70 | FFAR4 (0.44) | FFAR4KDM4ECASP1CASP7KMT2A | |
| SCHEMBL5722878 | 0.69 | CYP19A1 (0.45) | FFAR4KMT2ANPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120145974-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120145974-A1 | CHROMENE COMPOUND | CRY2, CYP2J2, NR0B2 | FFAR4 3957/4885KDM4E 3039/4885CASP1 1176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.